| Summary Of Investments Held By The Plan |
Investments held by the Plan on June 30, 2026, and 2025 were as follows:
| | | | | | | | | | | | | | | | 2026 | 2025 | | (All numbers in Euros) | Number | Market | Number | Market | | of Shares | Value in €uros | of Shares | Value in €uros | | Investments of each FCPE | | | | | | | | | | | • Groupe Procter & Gamble Actions ("Diversifié Dynamique" - A) * | 191,471 | | 35,099,724 | | 192,065 | | 29,173,094 | | | • Groupe Procter & Gamble Obligations ("Monétaire" - B) * | 555,710 | | 17,032,977 | | 544,436 | | 16,351,548 | | | • Groupe Procter & Gamble 5000 ("Actions Internationales" - C) * | 695,391 | | 38,987,607 | | 647,345 | | 27,681,676 | | | • Groupe Procter & Gamble ("Actionnariat" - D) * | 310,037 | | 130,345,726 | | 316,429 | | 134,927,478 | | | • Groupe Procter & Gamble Obligations ("Obligations" - F) * | 2,734,146 | | 4,335,810 | | 2,720,879 | | 4,235,761 | | | | | | | | Total investments | | 225,801,843 | | | 212,369,557 | |
*Represents investments which exceed five percent of net assets available for benefits The Plan’s investments experienced unrealized (depreciation) appreciation in value as follows for the years ended June 30, 2026, 2025 and 2024:
| | | | | | | | | | | | | (All numbers in Euros) | 2026 | 2025 | 2024 | | | | | | The Procter & Gamble Company Common stock (FCPE Option D) | | | | Cost | 102,332,314 | | 101,281,311 | | 93,635,079 | | | Market value | 130,345,726 | | 134,927,478 | | 145,525,742 | | | Unrealized appreciation (depreciation) | 28,013,412 | | 33,646,167 | | 51,890,663 | | | | | | | (Decrease) increase in unrealized appreciation | (5,632,754) | | (18,244,496) | | (24,341,734) | | | | | | | Other investments (FCPE Option A, B, C, F) | | | | | Cost | 75,918,024 | | 66,673,078 | | 61,468,575 | | | Market value | 95,456,117 | | 77,442,079 | | 73,247,110 | | | Unrealized appreciation (depreciation) | 19,538,092 | | 10,769,000 | | 11,778,535 | | | | | | | Increase (decrease) in unrealized appreciation | 8,769,092 | | (1,009,535) | | 2,657,131 | |
The realized gain (loss) on the sales of the Plan’s investments for the years ended June 30, 2026, 2025, and 2024 was determined as follows:
| | | | | | | | | | | | | (All numbers in Euros) | 2026 | 2025 | 2024 | | | | | | The Procter & Gamble Company Common stock | | | | | Proceeds on sales of shares | 15,203,358 | | 30,075,121 | | 75,122,493 | | | Cost | 13,171,927 | | 21,296,969 | | 36,804,241 | | | Realized (loss) gain | 2,031,431 | | 8,778,152 | | 38,318,252 | | | | | | | Other investments | | | | | Proceeds on sales of shares | 48,350,318 | | 54,472,212 | | 41,364,927 | | | Cost | 41,774,488 | | 49,261,953 | | 37,454,737 | | | Realized (loss) gain | 6,575,830 | | 5,210,259 | | 3,910,190 | |
|